Pharmaceutical Technology on MSN
BMS bets on Janux’s novel solid tumour therapy through $850m deal
This deal marks another addition to BMS’s growing pipeline, which the company hopes will stave off the impacts of the ...
D Path’s QPOR™ Platform Selected to Predict Patients’ Responses to TherapyNEWTON, Mass., Jan. 22, 2026 (GLOBE NEWSWIRE) -- 4D ...
Researchers at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) were recently ...
FDA fast-tracks novel Parkinson’s cell therapy NouvNeu001, advancing treatment for dopaminergic neuron loss and motor ...
A novel treatment that uses a disintegrating matrix for sustained release of medication led to improvement in vision and reduced supplemental treatment in patients with diabetic macular edema, ...
Sterol regulatory element-binding protein 1 (SREBP1), a key regulator of lipogenesis, is highly expressed in tumors, but the ...
Zacks Investment Research on MSN
FDA grants breakthrough therapy tag to LLY's ovarian cancer candidate
Eli Lilly and Company LLY announced that the FDA has granted a Breakthrough Therapy designation to its novel folate receptor ...
Jaguar has received the initial $16M payment related to the company's recently executed US out-license agreement for ...
A study led by the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong ...
Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model ...
Curiosity and creativity keep relationships alive by helping partners see each other as evolving, complex, and worthy of ...
This year, JPM 2026 took place again in San Francisco. Let’s look at predictions and trends forecast for 2026, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback